Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) – 2020 to 2025

$3,850.00$5,850.00

Published on: March 24, 2020
Clear
SKU: GMS-2126 Category:

OVERVIEW

The market for immunoprecipitation is expected to hit USD 873 million by 2025, rising over the forecast period at a CAGR of 4.65%. The research in the life sciences industry and the increasing need to classify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop specific drugs targeted at these diseases) drive growth of this market.

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 1

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 2

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 3

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 4

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 5

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 6

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 7

Immunoprecipitation Market by End User (Pharmaceutical and Biotechnology Companies, Academics, Research Institutes), Product (Kit, Reagent), Type (CHIP, Individual IP, Coimmunoprecipitation) - 2020 to 2025 8

TABLE OF CONTENT

1 Global Immunoprecipitation Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Immunoprecipitation Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Immunoprecipitation Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Immunoprecipitation Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Immunoprecipitation Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Immunoprecipitation Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Immunoprecipitation Market – By Product (Market Size – & million/billion)
8.1 Kits
8.2 Reagents
8.3 Accessories

9 Global Immunoprecipitation Market – By Type
9.1 Individual IP
9.2 co-IP
9.3 ChIP
9.4 RIP

10 Global Immunoprecipitation Market – By End-User
10.1 Academic & Research Institutes
10.2 Pharmaceutical and Biopharmaceutical Companies
10.3 Contract Research Organizations

11 Global Immunoprecipitation Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Immunoprecipitation Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Immunoprecipitation Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific
13.3 Abcam
13.4 Genscript
13.5 Rockland Immunochemicals
13.6 Cell Signaling Technology
13.7 Geno Technology
13.8 Merck KGaA
13.9 Bio-Rad Laboratories
13.10 Biolegend
13.11 Takara Bio
13.12 Company 11 & more

14 Global Immunoprecipitation Market – Appendix
14.1 Sources
14.2 Abbreviations